JDG — Judges Scientific Income Statement
0.000.00%
- £403.99m
- £459.99m
- £133.60m
- 83
- 18
- 36
- 39
Annual income statement for Judges Scientific, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 79.9 | 91.3 | 113 | 136 | 134 |
Cost of Revenue | |||||
Gross Profit | 48.9 | 58 | 77.1 | 94.8 | 92 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 69.8 | 75.7 | 95.1 | 114 | 117 |
Operating Profit | 10.1 | 15.6 | 18.1 | 21.7 | 16.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.47 | 14.9 | 16 | 13.4 | 13 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.65 | 12.9 | 12.8 | 9.9 | 10.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 8.22 | 12.7 | 12.4 | 9.5 | 10.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8.22 | 12.7 | 12.4 | 9.5 | 10.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.57 | 2.11 | 2.32 | 1.45 | 2.05 |
Dividends per Share |